BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 2, 2026
Home » Authors » Katie Pfaff

Katie Pfaff

katie.pfaff@clarivate.com
Articles

ARTICLES

Roche wins FDA nod for Zika screening test

Oct. 9, 2017
By Katie Pfaff
Roche Molecular Systems Inc. was awarded FDA approval for its donor-screening blood test for the Zika virus. The cobas test, which can be run on cobas 6800 or 8800 systems, is the first of its kind for commercial screening.
Read More

Animas to leave U.S., Canadian insulin pump market, customers transitioning to Medtronic

Oct. 6, 2017
By Katie Pfaff
Animas Corp., a Johnson & Johnson diabetes care company will leave the insulin pump market in the U.S. and Canada, and discontinue its Animas, Vibe and Onetouch Ping insulin pumps. The company will manage a transition to alternate devices for its patients, working with chosen partner, Medtronic plc, in that effort.
Read More

Nexxt Spine wins FDA nod for Matrixx spinal system

Oct. 5, 2017
By Katie Pfaff

Enteromedics acquires Reshape Medical and obesity balloon system

Oct. 4, 2017
By Katie Pfaff

Panel says 3-D printing opens many possibilities in med-tech production

Oct. 2, 2017
By Katie Pfaff

Med tech looks more attractive to investors under evolving conditions

Sep. 29, 2017
By Katie Pfaff

Nelson says Medical device cybersecurity needs to be addressed by manufacturers

Sep. 28, 2017
By Katie Pfaff

Disruption and change on tap for med-tech industry, says panel on future of leadership

Sep. 28, 2017
By Katie Pfaff
SAN JOSE, Calif. – Panelists tackled data, innovation and changes organizations need to make to adapt to the upcoming trends in a session at the Advance Medical Technology Association's (AdvaMed) MedTech Conference. An all-female panel of speakers discussed what leadership should do to prepare for business movement toward big data and machine learning, consumer trends and valuing people in an organization at "The future of leadership in medtech: trends of disruption and consolidation" panel.
Read More

Artificial intelligence shows promise to enhance devices with careful oversight

Sep. 27, 2017
By Katie Pfaff

Panelists say big deals, investment continue in med-tech industry

Sep. 27, 2017
By Katie Pfaff
View All Articles by Katie Pfaff

Popular Stories

  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing